[Carbamazepine-induced agranulocytosis. Apropos of 2 cases].
Carbamazepine-induced agranulocytosis (CIA) is a rare event. We report on two cases, highlighting the wide variability of the bone marrow, which may show pseudohypercellularity with disappearance of neutrophils and excess of immature cells (myeloblasts and promyelocytes), thus mimicking the features of acute myeloid leukemia. Although its pathogenesis is still unclear, CIA must be considered as an idiosyncratic hemopathy and moreover it appears to be an unpredictable complication among patients taking the drug. It should be clearly distinguished from the benign neutropenia frequently associated with carbamazepine therapy and often self-limiting. Anyhow a careful clinical and hematological monitoring is the only mean to recognize promptly this life-threatening disease and to treat it with the withdrawal of the drug and the administration of an adequate anti-infectious therapy.
Banfi
L
L
Divisione di Medicina II, Ospedale, Saronno.
Ceppi
M
M
Colzani
M
M
Guzzini
F
F
Morena
R
R
Novati
P
P
D000368:Aged; D000369:Aged, 80 and over; D000380:Agranulocytosis / Q000139:chemically induced* / Q000175:diagnosis; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D001856:Bone Marrow Examination; D002220:Carbamazepine / Q000009:adverse effects*; D006801:Humans; D008297:Male
D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D002220:Carbamazepine
Agranulocitosi indotta da carbamazepina. A proposito di due casi.